1
Return

Prehabilitation in oncological patients undergoing major gastrointestinal surgery: rationale and design of the PROGRESS trial

delete2026-02-01
delete0
PRE
AI
F
Federico Mattia Oliva
S
Stefano Turi
M
Marta Veneziano
F
Filippo D'Amico *
P
Passuello, Nicola
L
Lisa Notarianni
C
Camilla Fiorindi
N
Noemi De Piccoli
L
Lorenzo Ripamonti
L
Laura Fossati
M
Monica Gualtierotti
M
Matteo Ghezzi
M
Massimo Vecchiato
D
Domenico Pontillo
S
Simone Priolo
C
Cristiano Marchetti
D
Daniele Sandonà
P
Perla Cicero
V
Vincenzo Nicastro
A
Arianna Fumagalli
S
Sarzo, Giacomo
P
Palina Kozhan
N
Nicolò Pecorelli
M
M. Pieri
F
Francesco Puccetti
S
Silvia Foti
A
Andrea TETTAMANTI
D
DIego Palumbo
G
Giovanna Basile
M
Marilena Marmiere
S
Stefano Fresilli
R
Rosa Labanca
A
Alessandro Pruna
L
Laura Pasin
P
Putzu, Alessandro
R
Romero, Carolina
K
Katia Donadello
S
Salvatore Sardo
T
Tiziana Bove
L
Luca Nespoli
G
Gabriele Baldini
K
Korzeniowska, Malgorzata
A
Andrea Vignali
B
Beretta, Luigi
DOI:10.1016/j.cct.2026.108249delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Background: Preliminary evidence suggests that multimodal prehabilitation may reduce postoperative complications in patients undergoing cancer surgery. However, its true effectiveness has yet to be fully demonstrated, and there are still significant gaps in knowledge that need to be addressed. Methods: This is a two-arm, multicenter, randomized controlled trial including 400 adult oncological patients undergoing major gastrointestinal surgery. Patients are randomized with a 1:1 allocation ratio either to receive a multimodal prehabilitation program in addition to standard care or standard care alone. The prehabilitation program consists of four weeks of intervention including exercise training, nutritional support, and psychological counseling. The standard of care is delivered in accordance with the Enhanced Recovery After Surgery (ERAS) pathways. Results: The trial is ongoing and currently recruiting. The primary outcome is the rate of patients experiencing major postoperative complications within 30 days after surgery. We hypothesize that prehabilitation will reduce this rate from 40% to 25%. Secondary outcomes include the time of functional recovery, length of hospital stay, and complication severity. Conclusion: The PROGRESS trial will provide data to assess whether a prehabilitation program can reduce major postoperative complications and facilitate recovery in patients undergoing major oncological gastrointestinal surgery. Trial registration: This trial was registered on ClinicalTrials.gov with the trial identification NCT06404489.
Keywords:
Prehabilitation
Postoperative complications
Cancer
Gastrointestinal
Anesthesia
Surgery

Journal

Contemporary Clinical Trials cover
Contemporary Clinical Trials
IF:
1.9
Papers:
197
Citations:
5.7K

Organization

U
university of florence
Scholars:
4.1W
Papers: 3.1W
Citations: 42
A
azienda ospedaliero universitaria careggi
Scholars:
6.8K
Papers: 5.2K
Citations: 25
H
hospital santa maria della misericordia
Scholars:
4.2K
Papers: 2.8K
Citations: 3
U
university of padua
Scholars:
4.0K
Papers: 1.5K
Citations: 0
F
fondazione irccs san gerardo dei tintori
Scholars:
397
Papers: 140
Citations: 0
U
university of verona
Scholars:
2.2K
Papers: 887
Citations: 0
V
Vita-Salute San Raffaele University
Scholars:
2.7W
Papers: 1.6W
Citations: 1.4W
I
IRCCS Ospedale San Raffaele
Scholars:
1.4W
Papers: 1.0W
Citations: 6.0K
Cited Papers

Cited Papers

Citing Papers

Citing Papers